Amicogen (XKRX:092040) Ending Cash Position : ₩24,333 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Amicogen Ending Cash Position?

Amicogen's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩24,333 Mil.

Amicogen's quarterly Ending Cash Position declined from Jun. 2023 (₩21,799 Mil) to Sep. 2023 (₩20,678 Mil) but then increased from Sep. 2023 (₩20,678 Mil) to Dec. 2023 (₩24,333 Mil).

Amicogen's annual Ending Cash Position declined from Dec. 2021 (₩26,916 Mil) to Dec. 2022 (₩20,210 Mil) but then increased from Dec. 2022 (₩20,210 Mil) to Dec. 2023 (₩24,333 Mil).

Amicogen Ending Cash Position Historical Data

The historical data trend for Amicogen's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Ending Cash Position Chart

Amicogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

21,481.18

30,803.92

26,916.07

20,209.88

24,333.34

Amicogen Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															20,209.88	30,089.85	21,798.84	20,677.68	24,333.34

Amicogen Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Amicogen's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20209.883	+	4123.459
	=	24,333

Amicogen's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	20677.678	+	3655.664
	=	24,333

Amicogen Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Amicogen's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicogen (XKRX:092040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852

Website

http://www.amicogen.com

Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines